In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Learn coding in Python, Go and Rust from Serdar Yegulalp, software dev specialist and senior writer at InfoWorld. Electron lets you build desktop web-UI apps, but ...